Psoriasis clinical trials
The registry lists 1,896 studies for Psoriasis across more than 10 countries. 232 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 1,310
- Status unknown
- 154
- Recruiting
- 152
- Terminated
- 103
- Not yet recruiting
- 72
- Withdrawn
- 46
Phase
- Phase 2
- 418
- Phase 3
- 364
- Phase 1
- 255
- Phase 4
- 250
- Early Phase 1
- 18
Where
- United States
- 705
- Germany
- 269
- Canada
- 266
- France
- 169
- China
- 167
- United Kingdom
- 138
Who runs them
LEO Pharma (77) · Novartis Pharmaceuticals (69) · Pfizer (54) · Amgen (51) · AbbVie (47) · Bristol-Myers Squibb (37) · Eli Lilly and Company (31) · Bausch Health Americas, Inc. (24)
Studies
Recruiting first, then most recently updated. Showing 50 of 1,896 — search for more.
- Comparative Study on Unani Formulation Vs Active Control in Plaque PsoriasisNot yet recruitingNCT07841314Phase 21 country
- A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in RomaniaRecruitingNCT075827831 country
- A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic ArthritisRecruitingNCT07801495Phase 21 country
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 12 countries
- Metabolic Profiling of Immune Responses in Immune-mediated DiseasesRecruitingNCT048648861 country
- Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisRecruitingNCT07362017Phase 31 country
- Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of PsoriasisNot yet recruitingNCT07817394Not applicable
- Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in CanadaRecruitingNCT073707661 country
- Modifying PEST for Psoriatic Arthritis ScreeningRecruitingNCT06382051Not applicable1 country
- The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin DiseaseRecruitingNCT07487831Phase 41 country
- A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque PsoriasisRecruitingNCT07724366Phase 31 country
- A Study of Zasocitinib in Adults With Non-pustular Palmoplantar PsoriasisNot yet recruitingNCT07752108Phase 3
- Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 InhibitorsRecruitingNCT06399432Not applicable1 country
- Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin DiseasesNot yet recruitingNCT078041341 country
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RecruitingNCT06857942Phase 41 country
- Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study CompletersNot yet recruitingNCT07791199Phase 3
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT06979453Phase 316 countries
- Cytokine Expression in Psoriasis Patients With and Without Joint InvolvementRecruitingNCT05307809Not applicable1 country
- A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisRecruitingNCT07013201Phase 25 countries
- A Phase 1 Study to Evaluate the Safety and Effects of a Single Dose of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults.Not yet recruitingNCT07792928Phase 11 country
- Determinants of Chronic Inflammatory Skin Disease TrajectoriesRecruitingNCT059281691 country
- A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA TherapeuticallyRecruitingNCT07654751Phase 41 country
- A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical PracticeRecruitingNCT077465831 country
- The CorEvitas Psoriasis (PSO) RegistryRecruitingNCT027073411 country
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisRecruitingNCT07219420Phase 313 countries
- CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness RegistryRecruitingNCT061009911 country
- PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional StudyRecruitingNCT076157121 country
- PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional StudyRecruitingNCT076486021 country
- A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque PsoriasisRecruitingNCT07780929Not applicable1 country
- Phase II Clinical Trial of SHR-1139 Injection in Patients With PsoriasisRecruitingNCT07719530Phase 21 country
- Multi-Omic SignAtures of Inflammatory Cutaneous DiseasesNot yet recruitingNCT07771673
- A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT04772079Phase 313 countries
- A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients With PsoriasisNot yet recruitingNCT06620692Phase 2
- An AI-Based Erythema Measurement System for Psoriasis LesionsNot yet recruitingNCT074943961 country
- A Clinical Trial of Antiplatelets in PsoriasisNot yet recruitingNCT07744191Phase 41 country
- Anti Inflammatory Diet With Physical Therapy on PsoriasisRecruitingNCT07736651Not applicable1 country
- Assessing Psoriasis Treatment OutcomesNot yet recruitingNCT07391423Not applicable1 country
- Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar PustulosisNot yet recruitingNCT07530367Phase 31 country
- A Study of HL40626S Tablets in Healthy AdultsNot yet recruitingNCT07736586Phase 11 country
- Nailfold Capillaroscopic Changes in PsoriasisRecruitingNCT076935951 country
- Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and EfficacyRecruitingNCT07546032Not applicable1 country
- The Effects of Audio-Based Therapy on Anxiety in PsoriasisRecruitingNCT07390487Not applicable1 country
- Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic ArthritisNot yet recruitingNCT07648836
- Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar PsoriasisNot yet recruitingNCT07713212Phase 41 country
- Skin Microbial Ecology in Atopic DermatitisRecruitingNCT041702441 country
- A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT07489885Phase 21 country
- SEquential Treatment of PSoriasis With BiologicsRecruitingNCT071878171 country
- A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in DermatologyNot yet recruitingNCT07481019Not applicable
- Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology PatientsRecruitingNCT06702293Not applicable1 country
- Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in SubjectsRecruitingNCT07204639Phase 21 country